MARCHEGIANI, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 11.048
NA - Nord America 10.842
AS - Asia 7.493
SA - Sud America 1.107
Continente sconosciuto - Info sul continente non disponibili 334
AF - Africa 244
OC - Oceania 26
AN - Antartide 1
Totale 31.095
Nazione #
US - Stati Uniti d'America 10.461
RU - Federazione Russa 4.395
SG - Singapore 2.869
CN - Cina 2.269
GB - Regno Unito 1.782
IT - Italia 1.453
BR - Brasile 902
DE - Germania 805
VN - Vietnam 658
HK - Hong Kong 603
SE - Svezia 578
FR - Francia 520
IE - Irlanda 518
FI - Finlandia 344
CA - Canada 244
KR - Corea 231
BD - Bangladesh 156
IN - India 147
JP - Giappone 139
NL - Olanda 133
UA - Ucraina 97
ES - Italia 89
MX - Messico 88
AR - Argentina 66
TR - Turchia 60
PL - Polonia 59
NG - Nigeria 54
ID - Indonesia 51
IQ - Iraq 48
ZA - Sudafrica 47
PK - Pakistan 45
CZ - Repubblica Ceca 44
AT - Austria 40
BE - Belgio 30
VE - Venezuela 30
EC - Ecuador 29
LT - Lituania 29
TG - Togo 27
MA - Marocco 26
CO - Colombia 23
UZ - Uzbekistan 23
CL - Cile 21
AU - Australia 20
PH - Filippine 19
TN - Tunisia 19
AZ - Azerbaigian 18
SA - Arabia Saudita 18
AE - Emirati Arabi Uniti 17
BJ - Benin 17
JO - Giordania 17
CH - Svizzera 16
EG - Egitto 16
JM - Giamaica 15
LV - Lettonia 14
PY - Paraguay 14
SI - Slovenia 12
IR - Iran 11
RO - Romania 11
IL - Israele 10
KE - Kenya 10
NP - Nepal 10
PE - Perù 10
KG - Kirghizistan 9
PT - Portogallo 9
GR - Grecia 8
KZ - Kazakistan 8
OM - Oman 8
AL - Albania 7
HU - Ungheria 7
MY - Malesia 7
BG - Bulgaria 6
CR - Costa Rica 6
HR - Croazia 6
LB - Libano 6
NO - Norvegia 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
DK - Danimarca 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
BO - Bolivia 4
ET - Etiopia 4
GA - Gabon 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
UG - Uganda 4
AM - Armenia 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
NI - Nicaragua 3
PA - Panama 3
TW - Taiwan 3
Totale 30.716
Città #
Moscow 1.621
Singapore 1.552
Ashburn 1.390
Southend 1.388
San Jose 1.077
Chandler 1.074
Dallas 1.015
Hong Kong 591
Verona 532
Dublin 505
Beijing 405
Council Bluffs 405
Munich 391
Woodbridge 351
New York 329
The Dalles 318
Jacksonville 314
Ho Chi Minh City 226
Los Angeles 209
Houston 201
Ann Arbor 185
Helsinki 175
Jinan 156
Lawrence 155
Princeton 155
Hanoi 154
Wilmington 143
Tokyo 116
Nanjing 112
Shenyang 110
Santa Clara 100
São Paulo 91
Redmond 90
Montréal 89
Buffalo 87
Redondo Beach 86
Hebei 78
Columbus 76
Turku 76
Milan 75
London 74
Orem 73
Tianjin 65
Bologna 63
Sindelfingen 61
Haikou 58
Chennai 56
Chicago 55
Rome 55
Seattle 55
Hangzhou 51
Montreal 51
Toronto 51
Guangzhou 49
Stockholm 49
Frankfurt am Main 48
Warsaw 48
Abuja 46
Mcallen 46
Changsha 45
Denver 45
Ningbo 45
Atlanta 43
San Francisco 43
Taiyuan 41
Seoul 40
Fairfield 39
Brooklyn 38
Amsterdam 37
Zhengzhou 37
Redwood City 36
Rio de Janeiro 35
Taizhou 35
Washington 35
Brno 34
Johannesburg 33
Poplar 33
Jiaxing 32
Nanchang 32
Phoenix 31
Brussels 30
Lancaster 30
Belo Horizonte 29
Mexico City 29
Vienna 28
Haiphong 27
Lomé 27
Da Nang 26
Falkenstein 25
Tashkent 22
Lanzhou 21
Nuremberg 21
Jakarta 20
Lappeenranta 20
Querétaro 20
Ankara 19
Fuzhou 19
Baghdad 18
Madrid 18
Manchester 18
Totale 18.513
Nome #
Risk assessment for pancreatic fistula after pancreaticoduodenectomy with preoperative computed tomography 451
APPLICAZIONE DEI CRITERI RADIOLOGICI DI FUKUOKA NELLO STUDIO DEGLI IPMN DEL PANCREAS: È POSSIBILE DISTINGUERE GLI IPMN CON DISPLASIA DI GRADO ALTO-MODERATO DA QUELLI DI BASSO GRADO? 341
Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA) 308
Genomic characterization of hepatoid tumors: context matters 261
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 252
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 252
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 249
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 246
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 243
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 237
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 235
A root-cause analysis of mortality following major pancreatectomy 232
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 228
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 222
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 221
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 221
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 221
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 218
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 217
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 216
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS) 215
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 214
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 213
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 211
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 210
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 206
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 201
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 201
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 196
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 196
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 195
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 195
Pancreatic Hepatoid Carcinoma: A Review of the Literature 194
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 192
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 191
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 188
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 188
Results of a surveillance protocol for pancreatic BD-IPMNs 186
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 186
An unforeseeable adverse event during ERCP 183
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 183
Alternative Fistula Risk Score for Pancreatoduodenectomy (a-FRS) Design and International External Validation 183
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 182
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 181
A randomized controlled trial of stapled versus ultrasonic transection in distal pancreatectomy 181
Serous Cystic Neoplasms 179
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 179
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 179
Imaging after pancreatic surgery: normal post-operative findings, early and late complications with emphasis on CT imaging 178
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 178
Endoscopic placement of pancreatic stent for "Deep" pancreatic enucleations operative technique and preliminary experience at two high-volume centers 178
Impact of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy: An analysis of 1500 consecutive cases 177
ASO Visual Abstract: Surgery for IPMN of the Pancreas—Preoperative Factors Tipping the Scale of Decision-Making 176
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 176
Pancreaticojejunostomy after pancreaticoduodenectomy: Suture material and incidence of post-operative pancreatic fistula 176
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 175
Branch Duct Intraductal Papillary Mucinous Neoplasms: Recommendations for Follow-Up and Surgery 175
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 174
Minimally invasive pancreatic surgery - a review 174
Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data 174
Pancreatoduodenectomy at the Verona Pancreas Institute: the Evolution of Indications, Surgical Techniques and Outcomes: A Retrospective Analysis of 3000 Consecutive Cases 174
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 171
Cystic Neoplasm of the Pancreas 171
Postoperative infections represent a major determinant of outcome after pancreaticoduodenectomy: Results from a high-volume center 171
Endoscopic Ultrasound Features Associated with Malignancy and Aggressiveness of Nonhypovascular Solid Pancreatic Lesions: Results from a Prospective Observational Study 171
Use of an intraoperative wound protector to prevent surgical-site infection after pancreatoduodenectomy: randomized clinical trial 171
Correlation between resection margin involvement and CT patterns of recurrence of pancreatic adenocarcinoma after surgery 170
TC in urgenza in pazienti sottoposti a chirurgia del pancreas: correlazione tra complicanze e tampone rettale o faringeo pre-operatorio 170
The management of intraductal papillary mucinous neoplasms of the pancreas 170
Non-inferiority of open passive drains compared with closed suction drains in pancreatic surgery outcomes: A prospective observational study 170
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 170
Acute pancreatitis after pancreatoduodenectomy: A prospective study of diffusion-weighted magnetic resonance imaging, serum biomarkers, and clinical features 169
Redefining the Role of Drain Amylase Value for a Risk-Based Drain Management after Pancreaticoduodenectomy: Early Drain Removal Still Is Beneficial 167
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 166
The Actual Prevalence of Symptoms in Pancreatic Cystic Neoplasms: A Prospective Propensity Matched Cohort Analysis 166
Quantitative Assessment of Pancreatic Texture Using a Durometer: A New Tool to Predict the Risk of Developing a Postoperative Fistula 165
CT texture analysis of ductal adenocarcinoma downstaged after chemotherapy 165
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 165
Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head 165
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 165
CT patterns of recurrence of pancreatic adenocarcinoma after surgery: is there a correlation with resection margin involvement? 164
Dislocation of intra-abdominal drains after pancreatic surgery: results of a prospective observational study 164
High-risk Pancreatic Anastomosis vs. Total Pancreatectomy after Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis 164
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 163
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 163
Postoperative Serum Hyperamylasemia (POH) Adds Sequential Value to the Fistula Risk Score (FRS) in Predicting Pancreatic Fistula after Pancreatoduodenectomy 163
Association between pancreatic intraductal papillary mucinous neoplasms and extrapancreatic malignancies 162
Implementation of a strategic preoperative surgical meeting to improve the level of care at a high-volume pancreatic center: a before-after analysis of 1000 consecutive cases 160
Clinical impact of the updated international postoperative pancreatic fistula definition in distal pancreatectomy 160
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 159
Love (Pancreatic Surgery) in the Time of Cholera (COVID-19) 158
Prevent Pancreatic Fistula after Pancreatoduodenectomy: Possible Role of Ultrasound Elastography 157
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 157
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 157
401 consecutive minimally invasive distal pancreatectomies: lessons learned from 20 years of experience 157
Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy 156
European evidence-based guidelines on pancreatic cystic neoplasms 156
Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation 156
Pancreaticojejunostomy With Externalized Stent vs Pancreaticogastrostomy With Externalized Stent for Patients With High-Risk Pancreatic Anastomosis: A Single-Center, Phase 3, Randomized Clinical Trial 155
Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS) 155
Totale 19.148
Categoria #
all - tutte 108.791
article - articoli 100.276
book - libri 0
conference - conferenze 5.129
curatela - curatele 0
other - altro 774
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.612
Totale 217.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.141 0 298 41 124 42 30 22 87 56 26 88 327
2022/20233.106 199 392 267 510 220 773 72 218 334 23 62 36
2023/20241.948 70 158 178 199 213 340 116 152 26 83 299 114
2024/20254.753 213 211 184 754 265 192 380 263 673 299 460 859
2025/202614.653 925 645 1.049 2.430 3.849 951 1.218 820 1.282 849 285 350
2026/2027433 188 245 0 0 0 0 0 0 0 0 0 0
Totale 31.095